{"groups":[{"description":"See Detailed Description\n\nAutologous Hematopoietic Stem Cell Transplantation: Undergo transplantation\n\nBortezomib: Given SC\n\nCyclosporine: Given IV\n\nCyclosporine: Given PO\n\nFludarabine Phosphate: Given IV\n\nLaboratory Biomarker Analysis: Correlative studies\n\nMelphalan: Given IV\n\nMycophenolate Mofetil: Given PO\n\nNonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Undergo transplantation\n\nPeripheral Blood Stem Cell Transplantation: Undergo transplantation\n\nSyngeneic Bone Marrow Transplantation: Undergo transplantation\n\nTotal-Body Irradiation: Undergo radiotherapy","id":"FG000","title":"Tandem Auto-/Nonmyeloablative Allo-HCT and Maintenance Therapy"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"32"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"32"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}